Cathie Wood adds NTLA
The stock is climbing sharply on steady volume after news that a prominent gene-editing-focused fund manager added over 110k shares, giving the move a calm, orderly feel rather than a volatile spike.
Sources: https://www.moomoo.com/hans/community/feed/tracking-cathie-wood-adding-over-110k-gene-editing-ntla-trimming, https://www.moomoo.com/community/feed/cat
Previous verdicts for NTLA
- AI Search: Barclays Underweight Initiation Pressures Intellia Therapeutics — 2026-10-06
- Commercial Caution — 2026-09-15
- Short interest spike weighs — 2026-09-09
- Short interest spike weighs — 2026-09-09
- Debt deal lifts stock — 2026-09-04
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works